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Abstract
Trace mineral studies involving metal ion chelators have been conducted in investigating the response of gene and protein expressions of certain
cell lines but a few had really focused on how these metal ion chelators could affect the availability of important trace minerals such as Zn, Mn, 
Fe and Cu. The aim of the present study was to investigate the availability of Zn for the treatment of MC3T3-E1 osteoblast-like cells and the
availability of some trace minerals in the cell culture media components after using chelexing resin in the FBS and the addition of
N,N,N’,N’-tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN, membrane-permeable chelator) and diethylenetriaminepentaacetic acid (DTPA, 
membrane-impermeable chelator) in the treatment medium. Components for the preparation of cell culture medium and Zn-treated medium have 
been tested for Zn, Mn, Fe and Cu contents by atomic absorption spectrophotometer or inductively coupled plasma spectrophotometer. Also, the
expression of bone-related genes (ALP, Runx2, PTH-R, ProCOL I, OPN and OC) was measured on the cellular Zn depletion such as chelexing
or TPEN treatment. Results have shown that using the chelexing resin in FBS would significantly decrease the available Zn (p<0.05) (39.4 ± 1.5
μ M vs 0.61 ± 10.15 μ M) and Mn (p<0.05) (0.74 ± 0.01 μ M vs 0.12 ± 0.04 μ M). However, levels of Fe and Cu in FBS were not changed by 
chelexing FBS. The use of TPEN and DTPA as Zn-chelators did not show significant difference on the final concentration of Zn in the treatment
medium (0, 3, 6, 9, 12 μ M) except for in the addition of higher 15 μ M ZnCl2  which showed a significant increase of Zn level in DTPA-chelated
treatment medium. Results have shown that both chelators gave the same pattern for the expression of the five bone-related genes between Zn-
and Zn+, and TPEN-treated experiments, compared to chelex-treated experiment, showed lower bone-related gene expression, which may imply that
TPEN would be a stronger chelator than chelex resin. This study showed that TPEN would be a stronger chelator compared to DTPA or chelex
resin and TPEN and chelex resin exerted cellular zinc depletion to be enough for cell study for Zn depletion. 
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Introduction*
Trace element Zn generally participates in a wide variety of 
cellular processes as a cofactor of more than 300 enzymes, and 
these enzymes affect most major metabolic processes (Beyer-
smann & Haase, 2001). The bioavailability of Zn in vitro, 
participated in cell proliferation and differentiation, and the 
possible way that Zn generally functions in the regulation of cell 
proliferation is through the enzyme systems that influence cell 
division and proliferation (Tapiero & Tew, 2003). Zn and some 
bone-related trace minerals are important in the study of 
membrane transport mechanisms and for the investigation of 
protein and gene expressions. At present, metal ion chelators such 
as chelexing resins, DTPA (diethylenetriaminepentaacetic acid), 
TPEN [N,N,N’,N’-tetrakis(2-pyridylmethyl) ethylenediamine], 
BAPTA [1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic 
acid] and its derivatives, EDTA (diaminoethanetetraacetic acid) 
and EGTA (ethyleneglycoltetraacetic acid) are being used for 
limiting the available metal ions contained in cellular medium 
(Aballay et al., 1995; Frederickson et al., 2002; Hyun et al., 
2001; Kanekiyo et al., 2000; Libin et al., 2002). These metal 
ion chelators not only bind with the target mineral for certain 
studies but also bind to any possible metal ion present in the 
medium system. Chelating agents like TPEN and DTPA are often 
used in Zn treatment studies. The depletion treatment/method has 
a direct impact on both intra- and extracellular concentrations 
of Zn and other trace minerals thus affecting cellular metabolism 
(Frederickson et al., 2002). Depletion of Zn by TPEN induced 
apoptosis in hepatocytes, whereas depletion of cellular Zn by 
DTPA did not induce apoptosis (Nakatini et al., 2000).
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Mouse calvariae MC3T3-E1 osteoblast-like cells have been 
studied for bone morphology, extracellular mineralization, 
growth factors and metabolism. Expression patterns for genes 
and proteins in response to trace minerals like Ca and Zn have 
been conducted using the MC3T3-E1 cells (Beyersmann & 
Haase, 2001). Osteoblasts produce osteoid and matrix vesicles 
to which Zn ions are either freely or loosely bound. The direct 
effect of Zn in osteoblasts is on the mineralization on the action 
of nucleation and mineral growth (Ovesen et al., 2001). It would 
be important to treat cells appropriately with the considerable 
amount of metal ions including Zn for each of different cell types. 
Zinc is known as to function on skeletal growth and bone 
metabolism. One of the major Zn deficiencies is characterized 
by growth retardation which would be affected by skeletal growth 
inhibition  in vivo and decreased cell proliferation and 
differentiation (Avery & Bettger, 1992; Perry et al., 1997; 
Telford & Fraker, 1995). In the need to properly treat the 
osteoblastic cells in bone study with the considerable amount 
of Zn and other trace metal ions present in cell culture medium, 
this study was conducted to generally (1) evaluate the status of 
Zn and other trace elements (Mn, Fe and Cu) by chelexing FBS 
in osteogenic cell culture media and its components (2) compare 
the chelating effect of TPEN and DTPA in the status of Zn and 
Fe in osteogenic cell culture media and its components, (3) 
investigate the effect of Zn on bone-related gene expressions of 
osteoblastic MC3T3-E1 cells under mild Zn-deficiency (using 
chelexed FBS) and severe Zn-deficiency (using TPEN). 
Materials and Methods
Chelation of Zn in MC3T3-E1 osteoblast-like cell medium. 
The availability of Zn in osteoblastic cell culture media was 
depleted by using Zn-chelexed fetal bovine serum (FBS), 5 μ M 
N,N,N’,N’-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN) 
and diethylenetriaminepentaacetic acid (DTPA) as Zn chelators. 
Both chelex resins for chelexing of Zn in FBS and DTPA as 
extracellular Zn chelator can be used in mild Zn deficient 
treatments. TPEN as intracellular Zn chelator, on the other hand, 
can be used in severe Zn deficient treatments. 
Mild Zn deficiency
The chelexing process of FBS was done as described in our 
previous paper (Cho et al., 2005). Chelex-100 exchange resin 
was purchased from Bio-Rad. ZnCl2 was purchased from Sigma 
and cell culture reagents such as FBS and basal media were 
purchased from GIBCO. Briefly, 5 g chelex-100 ion exchange 
resin was added to 100 mL FBS and stirred overnight at 4℃. 
The FBS supernatant was taken and was filter-sterilized into 
polyethylene centrifuge tubes after the removal of resin. At this 
stage, Zn which already combined to chelex resin can be 
discarded and Zn-eliminated FBS can be used for Zn-depleted 
culture media composition. The chelexed FBS was then added 
to the osteogenic differentiation medium with a final con-
centration of 10%. Different levels of Zn (0, 3, 6, 9, 12 and 
15 μ M ZnCl2) were added to the media prior to cell treatment.
Severe Zn deficiency
N,N,N,’,N’-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) 
and diethylenetriaminepentaacetic acid (DTPA) were purchased 
from Sigma. Exposure to TPEN and DTPA was accomplished 
by direct addition of the calculated volume based on the stock 
solution to the cell culture treatment media in a final con-
centration of 5 μ M and 1.2 mM, respectively. The added TPEN 
(intracellular Zn chelator) and DTPA (extracellular Zn chelator) 
could bind with Zn and thus prevent cellular uptake of Zn 
bioavailability in cells. The various concentrations of Zn (0, 3, 
6, 9, 12 and 15 μ M ZnCl2) were then added to the culture 
treatment media.
Preparation of media samples and mineral analysis
Fresh media samples were collected and wet-digested in 
preparation for mineral analysis. Nitric acid (1 mL) was added 
to the fresh media samples (0.5 mL) and digested overnight on 
a hooded heating block. On the following day, distilled/deionized 
water was added to the digested samples. The solution obtained 
was used directly to determine the mineral content (Zn, Fe, Cu 
and Mn) using an atomic absorption spectrophotometer (Spec-
trAA 220 FS, Varian, Australia). The accuracy of the method 
for mineral analysis was evaluated using bovine liver standard 
reference material (SRM) obtained from the National Institute 
of Standards and Technology (NIST SRM 1577b, USA).
RT-PCR for bone-related gene expression
MC3T3-E1 cells were cultured in regular growth medium (α- 
MEM +10% FBS +100 units/mL penicillin +100 μ g/mL strep-
tomycin) until they reached 100% confluency. The regular 
growth medium was then replaced with an osteogenic differ-
entiation media (growth medium +10 mM β -glycerophosphate 
+50 μ g/mL ascorbic acid) and only two Zn levels: Zn- and Zn+ 
as described below for chelexing FBS or TPEN treatment. Two 
parallel treatments were done in the chelation of Zn: through 
addition of 5 μ M TPEN and through addition of chelexed-FBS 
in the treatment medium. MC3T3-E1 cells were harvested after 
5 days of treatment and subjected to gene expression analysis. 
The addition of Zn varied in concentration between chelexed FBS 
and TPEN-treated differentiation medium. Zn treatment using 
chelexed FBS used the Zn concentrations of 0 (Zn-) and 15 μ M 
ZnCl2 (Zn+) while Zn treatment using TPEN used the Zn 
concentrations of 1 (Zn-) and 15 μ M ZnCl2 (Zn+). Supple-
mentation of Zn must be given with the TPEN-treated medium 
since cells often died within 5 days of treatment (data not shown). Young-Eun Cho et al. 31
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Fig. 1. Trace mineral (Zn, Mn, Fe and Cu) composition of various cell culture 
media components using chelexed FBS in different media (n=2)
Different letter superscripts mean significantly different between media composition 
a t  p < 0 . 0 5  b y  T u k e y ,  o n e - w a y  A N O V A .  [ A ,  α M E M  ( f r e s h ) ;  B ,  F B S  ( f resh);  C, 
chelexed FBS; D, αMEM +10% FBS; E, αMEM +10% chelexed FBS; F, αMEM 
+ 1 0 %  c h e l e x e d  F B S  + 1 5  μ M  Z n C l 2 ;  G ,  D M E M ;  H ,  D M E M  + 1 0 %  F B S ] .
Osteoblastic bone marker gene expressions (ALP, Runx2, PTH 
receptor, procollagen type I, osteopontin, and osteocalcin) were 
measured by reverse-transcriptase-PCR. The primers for each 
gene were reported in the previous study (Cho et al., 2005). For 
first-strand cDNA synthesis, 100 ng of RNA from each sample 
was reverse transcribed using 20 U of AMV reverse transcriptase 
and Oligo-p (dT) 1 X random primers (Roche Diagnostics, USA). 
The resulting cDNAs were PCR-amplified by using a mixture 
of the corresponding sense and antisense primers. The PCR 
conditions were 95℃ for 2 min and then 30 cycles at 95℃ for 
30 s, 54℃ for 45 s and 72℃ for 1 min and a final extension 
at 72℃ for 5 min. The PCR products were separated on 1.8% 
agarose gel.
Statistical analysis
All values were presented as mean ± SEM. Data were analyzed 
using SPSS program and differences were considered significant 
as p < 0.05. Statistical analysis of the data was performed by 
one-way ANOVA to test the effect of various Zn levels. Once 
significance was detected among the various Zn levels, Turkey’s 
HSD test was used for comparison of the difference between 
groups.
Results 
Effect of using chelexed FBS on the mineral (Zn, Mn, Fe and 
Cu) content of cell culture media components
New cell culture media components were tested for trace 
mineral content - Zn, Mn, Fe and Cu - as shown in Figure 1. 
Zinc is an important trace mineral that is needed by many 
biological enzymes and was the target mineral of our study. Fresh 
α-MEM contained 0.23 ± 0.080 μ M Zn which was considered 
to be absent in the basal media (Fig. 1). Fresh FBS was found 
to have a significantly higher amount of Zn, 39.37 ± 1.46 μ M. 
However, chelexing FBS resulted in the decrease in the 
availability of Zn in fresh FBS which had an amount of 0.61
±0 . 1 5  μ M Zn. The addition of 10% fresh FBS to α-MEM 
(as control medium) resulted in a diluted Zn content (3.36 ± 0.00 
μ M Zn). The addition of 10% chelexed FBS to α-MEM, on 
the other hand, resulted in a sudden decrease of Zn level in the 
fresh medium. This confirms that chelexing FBS decreases the 
available Zn in fresh medium. The addition of 15 μ M Zn in 
a mixture of α-MEM and 10% chelexed FBS showed the 
concentration of 12.31 ± 0.23 μ M Zn which was significantly 
higher than the control medium containing 10% fresh FBS in 
α-MEM. Similar test was done to the DMEM and DMEM +10% 
FBS, which showed a similar pattern with α -MEM and α -MEM 
+10% FBS. 
Manganese is also an important trace mineral which is affected 
by the chelaxing resin (Chelex 100) used in the experiment. Fresh 
α -MEM contained 0.12 ± 0.01 μ M Mn and fresh FBS contained 
0.74 ± 0.01 μ M Mn. After the chelation of FBS, the Mn concen-
tration was significantly decreased to 0.12 ± 0.04 μ M. The 
addition of 10% FBS to α -MEM resulted in a final Mn 
concentration of 0.36 ± 0.08 μ M which was not significantly 
different from Mn concentration of α -MEM +10% chelexed FBS 
and  α -MEM +10% chelexed FBS +15 μ M ZnCl2  which had 
values of 0.36 ± 0.02 and 0.37 ± 0.06 μ M, respectively. Results 
suggest that the chelation of FBS will not significantly change 32 Cellular Zn depletion by TPEN, DTPA and chelexing
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Fig. 2. Trace mineral (Zn, Mn, Fe and Cu) composition of osteoblastic cell 
culture media with various Zn levels using chelexed FBS (n=2)
Zn-treated  Media  (0-15  μM  Zn)  were  prepared  as  the  addition  of  0  to  15  μM 
Zn  as  ZnCl2  to  a-MEM  plus  chelexed  FBS.  Different  letter  superscripts  mean 
significantly different between Zn media treatments at p<0.05 by Tukey, one-way 
ANOVA.
the availability of Mn in the control and treatment media.
Another important trace mineral is Fe which also can be 
affected by the chelation of FBS with the chelexing resin. In 
α -MEM, Fe was found to be absent. Fresh FBS, however, 
contained a significantly higher amount of Fe, 40.65 ± 1.25 μ M. 
Chelaxing FBS resulted in a decrease in concentration of 37.60
±2 . 3 3  μ M but was found to be not significantly different from 
the fresh FBS. Addition of 10% fresh FBS to α -MEM resulted 
in a decreased amount of Fe which could be based on the dilution 
of the FBS to the Fe-free α -MEM. The Fe content of the mixtures 
of α -MEM +10% fresh FBS and α -MEM + chelexed FBS were 
not significantly different having 3.76 ± 0.18 μ M and 3.04 ± 0.36 
μ M Fe, respectively. Moreover, the addition of 15 μ M ZnCl2 
to α -MEM + chelexed FBS, did not affect the Fe concentration 
either, as expected. Fresh DMEM, on the other hand, contained 
higher amount of Fe than with fresh α -MEM, even without 
significance. However, similar pattern was observed upon the 
addition of fresh 10% FBS to DMEM and 10% FBS to α -MEM.
Copper is found to have a significant relationship with Zn in 
several antioxidant proteins. Also, Cu is found to be affected 
by the chelating resin used in this study. There were no 
significant differences in the Cu content between the cell media 
components. 
Effect of chelexed FBS on the mineral (Zn, Mn, Fe and Cu) 
content of Zn-treated medium
Since we confirmed the significant decrease in the availability 
of Zn in the culture media and its components, we therefore 
determined the mineral content of the treatment medium with 
various levels of Zn. Figure 2 shows the effect of using chelexed 
FBS on the contents of Zn, Mn, Fe, and Cu in the different 
Zn-treated medium. It must be noted that a new batch of FBS 
and chelexed FBS were used in this part of the experiment and 
that the range for values still fell at the same level. The trace 
mineral levels of FBS and chelexed FBS in Figure 1 may slightly 
vary from the values of FBS and chelexed FBS in Figure 2.
The Zn level of the treatment medium resulted in an expected 
pattern. The Zn content of FBS was significantly dropped from 
43.38 ± 0.04 μ M to 0.562 ± 0.04 μ M after chelexing the FBS. 
The addition of Zn (0, 3, 6, 9, 12, and 15 μ M Zncl2) increased 
the availability of zinc in the treatment medium. The Mn level, 
on the other hand, showed no significant difference between the 
chelexed FBS and the different Zn-treated culture medium. Fe 
and Cu showed the same pattern as with the level of Mn with 
no significance between the chelexed FBS and the different 
Zn-treated culture medium.
Effect of TPEN and DTPA chelators on Zn-treated medium
Unlike the chelexing resin, TPEN and DTPA are metal ion 
chelators that are being added directly to the treatment medium. 
The effect of TPEN as an intracellular (membrane-permeable) 
chelator of Zn would result in severe Zn-deficiency whereas 
DTPA as an extracellular (membrane-impermeable) chelator 
show relatively similar effect with FBS-chelaxing which would 
result in mild Zn-deficiency. In this part of the study, DTPA 
was used as a substitute for chelexed FBS. Figure 3. shows the 
mineral contents of different medium composition and Zn-treated 
medium with the addition of both TPEN and DTPA. Fresh α 
-MEM contained no Zn whereas growth media contained 2.33
±1 . 4 0  μ M Zn. Upon the addition of TPEN and DTPA in the 
osteogenic differentiation media, Zn levels for both chelators 
were found to be at the same level with 4.88 ± 0.02 and 4.86Young-Eun Cho et al. 33
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Fig. 4. Bone-related gene expressions in osteoblastic MC3T3-E1 cells at 5 
days of Zn treatment using A) chelexed FBS and B) TPEN in Zn-treated 
osteogenic differentiation medium
Asterisks  (*)  mean  significantly  different  between  Zn  treatments  (Zn-  vs  Zn+)  at 
p<0.05  by  one-way  ANOVA.
±0 . 1 8  μ M Zn, respectively. Addition of 0, 3, 6, 9 and 12 μ M 
ZnCl2 showed no significant difference between the TPEN- and 
DTPA-chelated Zn-treated medium. Addition of 15 μ M ZnCl2, 
however, resulted in higher Zn level in DTPA-chelated medium 
than TPEN with Zn concentrations of 23.07 ± 0.28 μ M and 20.91
±0 . 0 4  μ M, respectively. 
Chelation of Fe through TPEN generally showed a lower value 
than with DTPA. However, there were significant differences in 
the Fe levels of Zn-treated medium of 0, 3 and 9 μ M ZnCl2. 
Levels of Fe in 0, 3 and 9 μ M ZnCl2-treated media were 
significantly lower in TPEN-chelated medium compared to 
DTPA- chelated medium with values of 1.88 ± 0.03, 1.90 ± 0.02 
and 2.18 ± 0.07 μ M vs 2.13 ± 0.00, 2.38 ± 0.06 and 2.58 ± 0.03 
μ M, respectively. 
Response of osteoblastic MC3T3-E1 cells on bone-related gene 
expressions by TPEN- and chelexed FBS-treated Zn treatment
MC3T3-E1 cells were treated with Zn- and Zn+ treatments 
with the use of chelexed FBS and TPEN in the treatment medium. 
Note that at Zn-, the concentration of Zn added to the chelexed 
FBS and TPEN-treated differentiation medium differed with 0 
and 1 μ M ZnCl2, respectively. This was intentionally done since 
the medium with chelexed FBS contained considerable amount 
of Zn that could still be utilized by cells within 5 days of 
treatment. The TPEN-treated medium, however, needed to be 
supplemented with Zn since TPEN is known to chelate metal 
ions severely, thus chelating almost all Zn ions present in the 
treatment medium. MC3T3-E1 cell was found to negatively 
respond (die) to TPEN-treated medium with 0 μ M ZnCl2. 
Five bone-related genes (ALP, Runx2, PTHR, Pro COL I, OPN 
and OC) were investigated on the effect of different Zn chelators, 
such as TPEN and chelexed FBS, in the treatment medium (Fig. 
4). Treatments for both chelexed FBS and TPEN showed similar 
pattern for all the genes mentioned above. Treatment with Zn+ 
increased the bone-related gene expressions of MC3T3-E1 cells. 
Discussion
Cell culture studies involving the bioavailability of Zn as a 
varying factor in metabolism and apoptosis have become 
interesting subjects in these days. Recent studies have shown that 
Zn plays a catalytic, co-catalytic and/or structural role in the 
proper folding of proteins (Bray & Bettger, 1990). Zinc ions exist 
primarily in the form of complexes with proteins and nucleic 
acids and participate in all aspects of intermediary metabolism. 
Zn has been found to maintain metallothionein tissue concen-
trations, stabilize the cell membrane, contribute to the structure 
of antioxidants such as SOD and facilitate in the regulation of 
expression of genetic information, storage and synthesis. Thus, 
Zn deficiency may cause direct and indirect imbalances in the 
cellular system which could lead to apoptosis (Perry et al., 1997; 34 Cellular Zn depletion by TPEN, DTPA and chelexing
Tapiero & Tew, 2003; Telford & Fraker, 1995).
Depletion of Zn prior to treatments in vitro is an important 
concern in cell culture study. Depletion of Zn in cell culture 
media can be achieved by using metal ion chelators such as 
chelexing resins, addition of metal ion chelators such as TPEN 
(membrane-permeable) and DTPA (membrane-impermeable), and 
other metal ion chelators which are not Zn-specific such as 
BAPTA (1,2-bis-(o-aminophenoxy)ethane-N,N,N’,N-tetra-acetic 
acid), EDTA (ethylenediaminetetraacetic acid) and EGTA 
(ethylene glycol tetraacetic acid) (Aballay et al., 1995; 
Frederickson et al., 2002; Hyun et al., 2001; Kanekiyo et al., 
2000; Libin et al., 2002). This study focused on the chelating 
effects of using chelexing resin, TPEN and DTPA on the 
bioavailability of Zn and other important trace minerals (Mn, 
Fe, and Cu) on the cell culture treatment media of osteoblastic 
MC3T3-E1 cells. 
Chelexing resin, TPEN and DTPA are metal ion chelators 
known to have high affinities with Zn. The present study focused 
on Zn and three bone-related minerals, namely Mn, Fe and Cu. 
The first chelexing treatment done for this study was by using 
Chelex-100 (Bio-Rad). Chelex 100 resin is a styrene divinyl-
benzene copolymer containing paired iminodiacetate ions which 
act as chelating groups in binding polyvalent ions. It has high 
preference for Cu, Fe, and other heavy metals over monovalent 
cations such as Na and K (Swanson & Feigenson, 1990). The 
selectivity of cations to bind chelex resins varies depending on 
the solution’s pH and composition. In an aqueous solution with 
pH 4, the selectivity for various cations is in the order of Cu
2+ 
> Zn
2+  > Fe
2+  > Mn
2+. In the presence of 1.5 M (NH4)2SO4 in 
aqueous solution with pH 9, the selectivity of cations applies 
only to copper and zinc (from the 4 trace minerals being studied) 
with an affinity of Cu
2+  > Mn
2+. In the presence of nitrate and 
chloride ions, chelex resin selectively binds to divalent cations 
with an order of selectivity of: Cu
2+ > Fe
3+ > Zn
2+ > Fe
2+ > 
Mn
2+. This would be the basis of the affinity of metal ions in 
this study since α -MEM contains chloride (Cl-) ions from 
inorganic salts such as CaCl2, KCl and NaCl. Based on the data 
presented, Zn and Mn were significantly decreased after 
chelexing FBS with resin (Figure 1: column B for FBS and C 
for chelexed FBS). Zn, the main trace element being studied, 
has been shown to significantly decrease the concentration of 
Zn in FBS to chelexed FBS from 39.37 ± 1.46 to 0.61 ± 0.15 
μ M. Also, the addition of 10% chelexed FBS to α -MEM would 
give a 3-fold decrease in Zn concentration to 10% normal FBS 
and α -MEM. Addition of 15 μ M ZnCl2  would result in appro-
ximately 12.31 ± 0.23 μ M Zn in α -MEM and 10% chelexed 
FBS.
The addition of various levels of Zn to the growth media using 
10% chelexed FBS was investigated in detail. Zn concentrations 
of 0, 3, 6, 9, 12 and 15 μ M ZnCl2 were added to the growth 
media using 10% chelexed FBS. The resulting concentration of 
Zn turned out as expected with an increasing Zn level pattern 
as the addition of Zn increased. Interestingly, the level of Mn 
(which has the least affinity with chelex resin among the 4 trace 
minerals being studied) was not changed significantly upon the 
addition of ZnCl2. This suggests that chelexing resin still binds 
effectively to the metal ion even with the least affinity. 
Furthermore, levels of Fe and Cu also remained at one level 
upon the addition of Zn. Results has confirmed that using 10% 
chelexed FBS in the Zn treatment of cell culture media would 
change the levels of Zn but not the other trace minerals.
The use of heavy metal ion chelators, TPEN and DTPA, was 
tried as the second treatment of chelation. N,N,N,’,N’-tetrakis 
(2-pyridylmethyl) ethylenediamine (TPEN) is a cell and nuclear 
membrane permeable heavy metal chelator with high affinities 
for Zn
2+ > Fe
2+  > Mn
2+. TPEN acts by chelating these ions in 
order of their affinities or combinations of these ions, thereby 
activating one or more metal-binding protein(s) (Shumaker, 
1998). Diethylenetriaminepenta-acetic acid (DTPA), on the other 
hand, is a hydrophobic and membrane-impermeable chelator that 
accesses the extracellular space and binds iron as well as other 
ions from the extracellular pool (Aisen & Listowsky, 1980). 
DTPA is an elongated version of EDTA and has been used to 
detoxify humans who are contaminated with plutonium, ameri-
cium and other actinides (Westin & Rasmuson, 2005). Cinatl 
et al. (1996) proposed that DTPA may directly interact with 
membrane associated proteins and lipids in in vitro study of virus 
for which Zn is a constituent of many proteins and enzymes. 
Previous studies have used DTPA in vitro in investigating the 
role of metal ions in cellular functions, particularly that of Zn 
(Chattopadhyay & Freake, 1998; Chesters et al., 1989; Lefebyre 
et al., 1998; Nakatani et al., 1998; Petrie et al., 1991).
TPEN was used in the cell culture media with a final 
concentration of 5 μ M while DTPA with 1.2 mM. Chelation 
of trace minerals using TPEN and DTPA were not significantly 
different with regard to the final concentration of Zn (Figure 
3). Levels for Cu and Mn were found to be chelated entirely 
by TPEN and DTPA (data not shown). The final concentration 
of Fe, however, showed a significant difference in 0, 3, and 9 
μ M ZnCl2. Lower levels of Fe in TPEN suggests that TPEN 
is a stronger chelator of metal ions than DTPA. With low levels 
of Fe and the absence of Mn and Cu, TPEN is better in chelating 
heavy metals than DTPA. 
Finally, bone-related gene expressions were investigated in 
response to TPEN and chelexed resin. Since Zn level in TPEN 
showed no significant difference from that in DTPA, TPEN was 
used for the cell culture treatment because this chelator can 
penetrate through the cell membrane as well as the nuclear 
membrane. Thus, Zn chelation with TPEN would cause severe 
Zn-deficiency to MC3T3-E1 cells while Zn chelation with chelex 
resin would cause mild Zn-deficiency. Bone-related gene 
expressions of ALP, Runx2, PTHR, ProCOL I, OPN and OC 
were highly expressed in Zn+ for both chelexed FBS and 
TPEN-treated culture medium. Also, TPEN-treated experiments, 
compared to chelex-treated experiment, showed considerably 
lower bone-related gene expression, which may imply that TPEN Young-Eun Cho et al. 35
would be a stronger chelator than chelex resin. In conclusion, 
this study showed that TPEN would be a stronger chelator 
compared to DTPA or chelex resin, and TPEN and chelexing 
resin can be used for the chelation of heavy metal ions especially 
Zn for osteogenic MC3T3-E1 cell culture condition. 
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